ClinicalTrials.gg
Not yet recruitingNCT06838663Updated Jun 24, 2025

Robotic-Assisted Total Knee Arthroplasty: Cruciate-Retaining Versus Bi-Cruciate Stabilized

An interventional study of Robotic assisted Cruciate-Retaining (CR) TKA procedures and Robotic assisted Bi-Cruciate Stabilized (BCS) TKA procedures in Knee Osteoarthritis and Total Knee Arthroplasty, sponsored by Chinese University of Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-24.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong — 9 open to participants now, 10 under way, none of them phase 3. Osteoarthritis, Knee · Chinese University of Hong Kong.

Planned enrollment
9th of 16
60 · median 64
Started
2025
the only one that year
No phase
15 of 20
8 open now
Registered
19th of 20
by date

Among the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong, this one is the 9th largest by planned enrollment of the 16 interventional ones that give a count, is the only one that started in 2025, is one of 15 with no phase, and was the 19th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

9 of the 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Osteoarthritis, Knee by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

The global prevalence of osteoarthritis of the knee with total knee arthroplasty performed is projected to substantially rise in the near future. This phenomenon is also observed in Hong Kong in which more than 4000 elective total joint replacement surgeries were performed in 2021 and over 30,000 patients are on the waiting list where some regions would have to wait for a median of more than 4 years. REAL INTELLIGENCE™ CORI™ (CORI Navigation) is a computer-assisted orthopedic surgical navigation and blurring system. CORI Navigation is designed to aid surgeons in planning and executing a procedure involving bone preparation for total knee arthroplasty (TKA) procedures. CORI Navigation is comprised of a console control unit, optical tracking camera, primary and secondary input displays (tablet and optional display monitor), and foot pedal. The CORI Navigation software consists of a patient and user management module, a surgical planner, and an intra-operative cutting module. Bi-Cruciate Stabilized (BCS) total knee arthroplasty (TKA) was designed for more kinematically functional implants that better reconstruct natural knee kinematics for activities of daily living. Surgical implant designs that resect the cruciate ligaments has emerged to simplify implantation and reduce surgical difficulty. The improvement of the biomechanical properties mimicking the natural kinematics of both the BCS and CR TKA may provide an effective solution to patient's dissatisfaction and impaired functional outcomes after surgery.

Read the detailed description

Arthritis is a clinical syndrome of joint pain accompanied by varying degrees of functional limitation and reduced quality of life. Two common etiologies of arthritis are degeneration of the joint, osteoarthritis (OA), and inappropriate inflammatory response, rheumatoid arthritis (RA). OA is characterized by loss of cartilage, remodeling of adjacent bone, and inflammation in the affected joint. RA is a progressive inflammatory disease that eventually causes systemic joint damage and disability. Post-traumatic arthritis is a form of osteoarthritis following an injury to a joint. Inappropriate joint biomechanics due to deformities is the main risk factor for OA. The joint biomechanics are directly affected by the malalignment of the lower extremities due to anatomical deformities. Varus deformity is an excessive inward angulation of the lower leg and results in a bowlegged appearance. It may cause an overloading and cartilage wear in the medial knee compartment, which could support a degeneration of the knee joint leading to OA.

As of 2010, there were approximately 250 million people globally with osteoarthritis of the knee joint (3.6% of the global population). The prevalence was higher in females than in males. Initial treatment of arthritis may include physical therapy, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and corticosteroids which can be taken orally or by injection.

Avascular necrosis (AVN) has several etiologies but fundamentally results from a decrease in blood flow to the affected bone, leading to cellular death. Studies have reported a 3.4% and 9.4% incidence of spontaneous osteonecrosis in persons older than 50 and 65 years of age, respectively. Initial treatment of AVN may include medication, stretching, and avoiding walking on the affected leg.

Complex epiphyseal fractures around the knee joint involve the distal femur or proximal end of the tibia. The management of these fractures, especially in elderly patients, is challenging. When the damage to the joint is advanced or available conservative treatment options are exhausted, knee arthroplasty is considered the most effective treatment for patients with any of these indications.

Total knee arthroplasty (TKA) is a highly successful and frequently performed surgical treatment to reduce disability caused by end-stage osteoarthritis and other conditions affecting articular cartilage. Technical outcomes for TKA are excellent, with favorable postoperative health-related quality of life. Also, survivorship of primary knee replacements is excellent with reported survivorship of 82.3% at 25 years. TKA has traditionally been indicated in the elderly population with relatively sedentary lifestyles, but more active, younger patients (\<55) are receiving TKA due to the desire for a pain-free, active lifestyle with the demand projected to continue to increase for this group. A recent systematic review has shown that functional outcomes are similar in this population compared to elderly patients with no increase in the burden of revision.

In Australia, 660,000 primary TKAs have been performed in 2018. Since 2003, the number of knee replacement procedures undertaken has increased by 128%. The escalating prevalence of end-stage OA places an increased burden on healthcare providers, especially on less experienced surgeons and facilities that perform low numbers of arthroplasties. Lower volume hospitals (\<25 procedures/year) report higher revision rates and more complications by 5 to 8 years compared to high volume hospitals (>200 procedures/year). Therefore, technology or techniques that could improve outcomes and reduce the risk of revision are becoming increasingly important.

Surgical factors that must be considered in knee arthroplasty include lower leg alignment, soft tissue balancing, maintenance of the joint line, and component size and fixation. Malalignment of components in any anatomical plane can cause major complications including aseptic loosening, instability, poor function, polyethylene wear, and pain. Additionally, implant malposition and malalignment of the joint can result in failure of the prosthesis. When not aligned within a narrow tolerance of ≤3° of the mechanical axis, poor functional outcomes, decreased implant survivorship, increased wear, and early failure from component loosening may occur.

Evidence has shown that neutral mechanical alignment provides optimal outcomes in knee arthroplasty, which is achieved with conventional alignment guides in approximately 75% of TKA cases. For partial knee procedures, approximately 30-60% of UKAs have been reported to be mal-aligned using conventional manual instruments. The importance of alignment can be demonstrated by observing higher revision rates of UKA attributed to malposition or malalignment of partial knees while roughly 25% of TKAs have been revised for instability or malalignment.

As an alternative to mechanical alignment, kinematic alignment technique for knee arthroplasty aims to restore the individual knee anatomy and ligament tension, to restore native knee kinematics. Kinematic alignment restores the obliquity and level of the joint line anatomically so the femoral component is slightly more valgus (1° to 2°) and the tibial component is slightly more varus (1° to 2°) than mechanically aligned components.

A significant innovation in knee arthroplasty has been the introduction of computer navigation and robotic-assisted surgery. One such technology is CORI. This system is a semi-autonomous image-free system. During the surgery, the surgeon maps the condylar landmarks and determines alignment indices to define the volume and orientation of bone to be removed. The tools to remove the bone and place the implants are controlled and manipulated by the surgeon with the guidance of a 3-dimensional digital map of the surgical surface.

Comparisons of navigation systems to conventional instruments have demonstrated that robotic platforms produce fewer positioning errors in both UKA and TKA. When used in medial or lateral UKA procedures, robotics reported short learning curves, increased accuracy in posterior tibial slope, and coronal tibial alignment in comparison to other alignment methods.

There are various total knee designs available in the market that promote their own benefits in restoring the natural kinematics of the knee to mimic the movement of the normal knee. Currently in our region, there are four commonly used robotic-assisted total knee arthroplasty designs available, which depend on the patient's factors and surgeon's preference. There is the Bi-Cruciate Retaining Total Knee Arthroplasty (BCR TKA), the Bi-Cruciate Stabilized Total Knee Arthroplasty (BCS TKA), the Posterior Stabilized Total Knee Arthroplasty (PS TKA), and the Cruciate Retaining Total Knee Arthroplasty (CR TKA).

The PS and BCS total knee arthroplasties are common choices as they sacrifice both the anterior cruciate ligament (ACL) and the posterior cruciate ligament (PCL) for simplification of implantation and reduction of surgical difficulty. The conventional PS TKA is a common feasible choice as it has shown long-term survivorship and acceptable patient outcomes. The BCS TKA similarly substitutes both the ACL and PCL but uses a unique dual cam-post mechanism to preserve normal knee kinematics and increase anterior-posterior stability throughout knee flexion.

On the other hand, preservation of the PCL in Cruciate Retaining (CR) total knee arthroscopy was traditionally believed to improve flexion and range of motion by restoring normal knee biomechanics and anatomical femoral rollback. PCL retention is also associated with better stairs performance, although the function of the PCL without the ACL is in debate. However, more recent studies have shown that there was a paradoxical anterior translation of the femur on the tibia during knee flexion, leading to the newer development of designs to retain both cruciate ligaments.

The Bi-Cruciate Retaining (BCR) total knee arthroplasty was designed for more kinematically functional implants that better reconstruct natural knee kinematics for activities of daily living by preserving both the anterior cruciate ligament (ACL) and the posterior cruciate ligament (PCL). BCR TKA historically has not been favored in the past due to its difficult surgical technique and complication rate, however, due to the recent emergence of new implant designs, it has gained back its popularity with improving functional outcomes and reducing complication rate. The ACL has been shown to be a factor for optimal knee kinematics and natural movement through its proprioceptive qualities. ACL deficient knees demonstrate posterior femoral position in full extension and increased medial femoral condyle translation during knee flexion. Preservation of both the ACL and PCL results in better flexion range, stability, and capacity to climb stairs.

On the other end of the spectrum, implant designs that resect the cruciate ligaments have emerged to simplify implantation and reduce surgical difficulty, such as the posterior cruciate retaining (PCR), posterior stabilized (PS), and the newer Bi-Cruciate Stabilized (BCS) total knee arthroplasty (TKA). In the normal knee, the lateral femoral condyle moves posterior across the tibial plateau with knee flexion, while the medial femoral condyle moves posterior in early flexion then anteriorly briefly before resuming posterior in the end of flexion. The BCS TKA is a convenient design that substitutes the sacrificed ACL and PCL with a unique dual cam-post mechanism to preserve normal knee kinematics and increase anterior-posterior stability throughout knee flexion.

The improvement of the biomechanical properties mimicking the natural kinematics of both the BCS and CR TKA may provide an effective solution to patient dissatisfaction and impaired functional outcomes after surgery. Therefore, an analysis of the knee kinematics of these patients with gait analysis, proprioception, and comparison of functional outcomes would aid the choice of implant.

Objective:

PRIMARY OBJECTIVE The primary objective of this study is to evaluate the use of CR and BCS in TKA procedure in achieving post-operative leg.

SECONDARY OBJECTIVE(S) The secondary objective of this study is to generate safety and performance evidence supporting the use of robotic assisted CR and BCS TKA procedures. To assess the safety and performance of robotic assisted CR and BCS TKA procedures up to 24 months after TKA surgery.

03

Conditions studied

  • Knee Osteoarthritis
  • Total Knee Arthroplasty

Keywords

  • Knee Osteoarthritis
  • Knee OA
  • Total Knee Arthroplasty
  • Robotic-assisted TKA procedure
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subject is a suitable candidate for a robotic-assisted TKA procedure
  2. Subject requires a cemented TKA as a primary indication that meets any of the following condition:

    • Degenerative joint disease, including osteoarthritis
    • Rheumatoid arthritis
    • Avascular necrosis
    • Requires correction of functional deformity
    • Requires treatment of fractures that were unmanageable using other techniques
  3. Subject is of legal age to consent and considered skeletally mature (≥ 18 years of age at the time of surgery)
  4. Subject agrees to consent to and to follow the study visit schedule (as defined in the study protocol and form), by signing the Ethical Committee (EC) or Institutional Review Board (IRB) approved informed consent form.
  5. Subject plans to be available through two (2) year postoperative follow-up.
  6. Applicable routine radiographic assessment is possible.

Exclusion criteria

Exclusion Criteria:

  1. Subject requires a TKA on the index joint as a revision for a previously failed surgery, or has the need for complex implants, or any other implant than a standard TKA (e.g. stems, augments, or custom made devices).
  2. Subject has been diagnosed with post-traumatic arthritis.
  3. Subject requires bilateral TKA.
  4. Subject does not understand the language used in the Form.
  5. Subject does not meet the indication or is for TKA according to the specific Smith Nephew Knee System's Instructions For Use (IFU).
  6. Subject has active infection or sepsis (treated or untreated).
  7. Subject is morbidly obese with a (BMI) greater than 40.
  8. Subject is pregnant or breast feeding at the time of surgery.
  9. Subject, in the opinion of the Investigator, has advanced osteoarthritis or joint disease at the time of surgery and was better suited for an alternate procedure.
  10. Subject has a condition(s) that may interfere with the TKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease, or an active, local infection).
  11. Subject in the opinion of the Investigator has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, intellectual disability, drug or alcohol abuse.
  12. Subject, in the opinion of the Investigator, has a neuromuscular disorder that prohibited control of the index joint.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Robotic assisted Cruciate-Retaining (CR) TKA procedures

    Patients who underwent Cruciate Retaining (CR) total knee arthroplasty (TKA)

    Procedure: Robotic assisted Cruciate-Retaining (CR) TKA procedures

  • Experimental
    Robotic assisted Bi-Cruciate Stabilized (BCS) TKA procedures

    Patients who underwent Bi-Cruciate Stabilized (BCS) total knee arthroplasty (TKA)

    Procedure: Robotic assisted Bi-Cruciate Stabilized (BCS) TKA procedures

Interventions

  • ProcedureRobotic assisted Cruciate-Retaining (CR) TKA procedures

    Patients who underwent Cruciate Retaining (CR) total knee arthroplasty (TKA)

  • ProcedureRobotic assisted Bi-Cruciate Stabilized (BCS) TKA procedures

    Patients who underwent Bi-Cruciate Stabilized (BCS) total knee arthroplasty (TKA)

06

What researchers measure

Primary outcomes

  1. Post-operative leg alignment - Standard Radiographic Evaluation

    The leg alignment should be measured from an antero-posterior (A/P) view standing weight bearing full leg ('long leg') x-ray. The following axes shall be identified: * Mechanical Axis of the femur: Axis from the center of the femoral head to the center of the distal femur. * Mechanical Axis of the tibia: Axis from the center of the proximal to the center of the distal tibia. Standard radiographic evaluation on antero-posterior (A/P) and lateral (L) views shall be performed 12\&24 months after surgery in order to identify any radiographic observations such as radiolucent lines around the implant components. The presence of radiolucent lines, osteolysis \& implant migration shall be recorded.

    Time frame: pre-operatively and 6 weeks, 12 weeks,12months and 24 months after surgery

Secondary outcomes

  1. 2011 Knee Society Score

    The 2011 KSS is a validated tool that combines an objective physician-derived component with a subjective subject-derived component. The 2011 KSS consists of 34 questions and provides sub-scores across 4 dimensions, including Objective Knee Score, Symptoms, Subject Satisfaction Score, Subject Expectation, and Functional Knee Score. The Objective Knee Score is rated by the clinician and assesses a range of clinical outcomes: TKA alignment, stability, range of motion (ROM) and symptoms. The Subject Satisfaction Score assesses the satisfaction with 5 daily activities (sitting, lying in bed, getting out of bed, light household duties, and leisure activities). The Subject Expectation Score evaluates the subject's expectations prior to surgery. The post-operative questions differ from the pre-operative questions and ask if the subject's pre-operative expectations have been met. As the pre- and post-operative scores are based on different questions, they cannot be directly compared.

    Time frame: pre-operative visit and 6 weeks, 6 months, 12 months, and 24 months after surgery

  2. Oxford Knee Score

    The Oxford Knee Score (OKS) is a Patient Reported Outcome (PRO) questionnaire that was developed to specifically assess the patient's perspective of outcome following Total Knee Arthroplasty. The OKS is a patient self-completion PRO containing 12 equally weighted questions on activities of daily living. The OKS has been developed and validated specifically to assess perceived function and pain answered on a Likert scale after TKA. Responses to each question ranges from 0-4 with a range of a possible overall score from 0-48. A score of 0 is the worst possible outcome while a score of 48 is the best possible outcome.

    Time frame: pre-operative visit and 6 weeks, 6 months, 12 months and 24 months after surgery

  3. Forgotten Joint Score

    The FJS comprises measures for the assessment of joint-specific patient reported outcomes. This questionnaire focuses on the study subject's awareness of the partially or fully replaced knee joint in everyday life. Joint awareness can be simply defined as any unintended perception of a joint. Subjects are asked to rate their awareness of their knee arthroplasty in 12 questions with a five point Likert response format: "Never", "almost never", "seldom", "sometimes" and "mostly". The item scores are summed and linearly transformed in a 0 to 100 scale with a high value reflecting the ability of the subject to forget about the replaced knee joint during the activities of daily living.

    Time frame: pre-operative visit and 6 weeks, 6 months, 12 months, and 24 months after surgery

  4. Knee Injury and Osteoarthritis Outcome Score

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a questionnaire designed to assess short and long-term patient-relevant outcomes following knee injury. The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life. The KOOS's five patient-relevant dimensions are scored separately: Pain (nine items); Symptoms (seven items); ADL Function (17 items); Sport and Recreation Function (five items); Quality of Life (four items). A Likert scale is used and all items have five possible answer options scored from 0 (No problems) to 4 (Extreme problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures. Scores between 0 and 100 represent the percentage of total possible score achieved

    Time frame: pre-operative visit and 6 weeks, 6 months, 12 months, and 24 months after surgery

  5. The Western Ontario and McMaster Universities Osteoarthritis Index

    The WOMAC is a widely used self-administered health status measure used in assessing pain, stiffness, and function in patients with OA of the hip or knee. It consists of three subscales: Pain: Measures the level of pain in the joint. Stiffness: Assesses the stiffness of the joint. Function: Evaluates the ability to perform daily activities such as walking, climbing stairs, and getting in and out of a chair. Minimum score: 0 (indicating no symptoms or functional limitations). Maximum score: 68 (for the original WOMAC scale, with higher scores reflecting greater severity of symptoms and limitations). Higher scores indicate worse outcomes, meaning more pain, more stiffness, and greater difficulty with daily activities. Lower scores suggest better joint health and function.

    Time frame: pre-operative visit and 6 weeks, 6 months, 12 months, and 24 months after surgery

  6. EQ-5D-5L

    The EQ-5D-5L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system is used to describe the subject's health state and consists of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels to choose the most appropriate answer: no problems, slight problems, moderate problems, severe problems, and extreme problems. The subject is asked to indicate his/her health state by marking the most appropriate statement in each of the five areas. The EQ VAS records the subject's self-rated health on a vertical visual analogue scale. The endpoints on the scale are labelled "The best health you can imagine" and "The worst health you can imagine". The VAS can be used as a quantitative measure of health outcome as judged by the individual respondents.

    Time frame: pre-operative visit as well as 6 weeks, 6- , 12 - and 24-months after surgery.

  7. Gait analysis

    The biomechanical analysis will include gait cycle analysis, sit-to-stand, and stairs assessment. The analysis will be conducted with sixteen reflective markers being attached to specific anthropometric landmarks determined by the analysis software NEXUS 1.8.3 (VICON, Oxford Metrics Ltd., UK) and captured by sixteen infrared cameras. Initially the kinematic anatomical angles from the markers will be captured in a static trial using Vicon's Plug-In Gait model and then the patients will be asked to walk on an embedded force plate to measure the kinetic variables, including vertical and horizontal ground rection force and joint movements. The kinematic and kinetic variables will be processed and calculated in the Matlab (The Mathworks Inc., Natick, Massachusetts, USA). The patients will be asked to walk straight, climb up and down stairs a self-selected speed, and rise from sitting on a chair without using their arms.

    Time frame: pre-operative visit as well as 6 weeks, 6- , 12 - and 24-months after surgery

  8. Proprioception

    The knee proprioception evaluation involved sensing of the joint position. An isokinetic dynamometer will be used in all of these procedures. All tests will be conducted with the patient in a seated position with the hip at approximately 90° and the entire back touching the backrest. The patient will be fixed to the seat by means of a belt.

    Time frame: pre-operative visit and 6 weeks, 6 months, 12 months, and 24 months after surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: starting 6 months after publication

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2025; primary completion for Jun 2027, 24 months later.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 24 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2025
First posted
Feb 21, 2025
StartEst.
Jun 2025
Primary completionEst.
Jun 2027
CompletionEst.
Jan 2028
Last update
Jun 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06838663
Responsible party
Prof. Tim-Yun Michael ONG (Clinical Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Feb 21, 2025
Start date
Jun 2025 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Jun 24, 2025

Study contacts

Tim-yun Michael Ong
Contact
michael.ong@cuhk.edu.hk
26364171

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion